Clinical Trial

A Study of BGM0504 Tablets in Healthy Chinese Subjects

Name: A Study of BGM0504 Tablets in Healthy Chinese Subjects — clinical trial record (NCT07566572)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

A randomized, open-label, multiple-dose study to evaluate the effects of high-fat meals and different administration conditions (including water intake and fasting time) on the pharmacokinetics of BGM0504 tablets at a dose of 20mg in healthy Chinese participants and to assess its safety and tolerability.

Trial Details

NCT Number	NCT07566572
Lead Sponsor	BrightGene Bio-Medical Technology Co., Ltd. Collaborators: BrightGene Pharmaceutical (Suzhou) Co., LTD
Conditions	Chinese Healthy Volunteers
Enrollment	144 participants
Start Date	2026-03-26
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-05